Cargando…

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment

BACKGROUND: Drug repositioning, development of new uses for marketed drugs, is an effective way to discover new antitumor compounds. In this study, we used a new method, filtering compounds via molecular docking to find key targets combination. METHODS: The data of gene expression in cancer and norm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yong, Li, Yiqun, Li, Dengke, Li, Kaiming, Quan, Zhengyang, Wang, Ziyi, Sun, Zhenxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062795/ https://www.ncbi.nlm.nih.gov/pubmed/32194417 http://dx.doi.org/10.3389/fphar.2020.00187

Ejemplares similares

Evaluation of mulberry leaves’ hypoglycemic properties and hypoglycemic mechanisms
por: Chen, Sikai, et al.
Publicado: (2023)

Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
por: Rabben, Hanne-Line, et al.
Publicado: (2021)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022)

Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis
por: Li, Yi, et al.
Publicado: (2020)

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
por: Chen, Yu-An, et al.
Publicado: (2018)

Post-marketing Study of Linagliptin: A Pilot Study
por: Gomes, Gabrielle Kéfrem Alves, et al.
Publicado: (2019)

Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
por: Mejía-Pedroza, Raúl A., et al.
Publicado: (2018)

Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
por: Menduti, Giovanna, et al.
Publicado: (2020)

Drug Repositioning in Glioblastoma: A Pathway Perspective
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Enhancing the Promise of Drug Repositioning through Genetics
por: Pritchard, Jayne-Louise E., et al.
Publicado: (2017)

Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD
por: Zhu, Yanlin, et al.
Publicado: (2020)

Blood Immune Cell Composition Associated with Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis
por: Liu, Jia-Chen, et al.
Publicado: (2021)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis
por: Liu, Jia-Chen, et al.
Publicado: (2022)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
por: Peña-Corona, Sheila I., et al.
Publicado: (2023)

Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
por: Mucke, Hermann A. M.
Publicado: (2017)

Drug-Repositioning Approaches Based on Medical and Life Science Databases
por: Zamami, Yoshito, et al.
Publicado: (2021)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021)

Lung adenocarcinoma-related target gene prediction and drug repositioning
por: Huang, Rui Xuan, et al.
Publicado: (2022)

Drug repositioning based on heterogeneous networks and variational graph autoencoders
por: Lei, Song, et al.
Publicado: (2022)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
por: Zhang, Yuchen, et al.
Publicado: (2022)

Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis
por: Khayat, Maan T., et al.
Publicado: (2022)

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2022)

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
por: Lee, Yueh-Ting, et al.
Publicado: (2021)

Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
por: Zhao, Zimo, et al.
Publicado: (2023)

Hypoglycemic effects of dendrobium officinale leaves
por: Lv, Ming, et al.
Publicado: (2023)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
por: Yamamoto, Shota, et al.
Publicado: (2021)

Targeting acetyl-CoA carboxylase 1 for cancer therapy
por: Yu, Yong, et al.
Publicado: (2023)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
por: Sestili, Piero, et al.
Publicado: (2020)

Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
por: Wang, Yixuan, et al.
Publicado: (2023)

Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
por: Zhu, Liyuan, et al.
Publicado: (2020)

Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning
por: De Bastiani, Marco A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4grt9gtkpms0ul8986e89kbmto